Skip to main content
See every side of every news story
Published • loading... • Updated

Lavipharm: Durogesic® Launched in France

Summary by sofokleousin.gr
Lavipharm expects significant revenue/profit from the distribution of the drug DUROGESIC® in many European countries.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

insider.grinsider.gr
Reposted by
iatronet.griatronet.gr

The Company continues the processes of transferring the marketing authorizations of Durogesic® to other markets.

Lavipharm expects significant revenue/profit from the distribution of the drug DUROGESIC® in many European countries.

It continues the procedures for transferring the marketing authorizations of DUROGESIC® to other markets and estimates that the relevant approvals will be completed in the near future.

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Capital.gr broke the news on Thursday, October 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal